Constanze Heinzel

Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children

B. Mordmüller, P. Kremsner, R. Fendel, 2021, Frontiers in Immunology.

Antibody binding and ACE2 binding inhibition is significantly reduced for the Omicron variant compared to all other variants of concern

K. Schenke-Layland, Jens Gruber, U. Rothbauer, 2022, medRxiv.

Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants

K. Schenke-Layland, U. Rothbauer, P. Kaiser, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Complementary methods for SARS-CoV-2 diagnosis in times of material shortage

P. Kremsner, R. Fendel, Juliana Inoue, 2021, Scientific reports.

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals

K. Schenke-Layland, M. Schindler, U. Rothbauer, 2021, Nature Communications.

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

H. Wertheim, J. Bukh, S. Justesen, 2023, The Lancet Microbe.

SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination

Douglas M. Consolaro, P. Kremsner, Meral Esen, 2021, Frontiers in Immunology.

Saliva and Plasma Antibody Levels in Children and Adolescents After Primary Infection With Omicron Variants of SARS-CoV-2 Infection in Germany.

P. Kremsner, R. Fendel, J. Held, 2023, JAMA pediatrics.

Prevalence of SARS-CoV-2 Infection in Children by Antibody Detection in Saliva: Protocol for a Prospective Longitudinal Study (Coro-Buddy)

R. Fendel, J. Held, A. Kreidenweiss, 2021, JMIR research protocols.